The role of tau (MAPT) in frontotemporal dementia and related tauopathies

Rosa V Rademakers, M. Cruts, C. Van Broeckhoven

Research output: Contribution to journalArticle

214 Citations (Scopus)

Abstract

Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. In patients diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17, mutations in the gene encoding tau (MAPT) have been identified that disrupt the normal binding of tau to tubulin resulting in pathological deposits of hyperphosphorylated tau. Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration. In the last five years, extensive research has identified 34 different pathogenic MAPT mutations in 101 families worldwide. In vitro, cell-free and transfected cell studies have provided valuable information on tau dysfunction and transgenic mice carrying human MAPT mutations are being generated to study the influence of MAPT mutations in vivo. This mutation update describes the considerable differences in clinical and pathological presentation of patients with MAPT mutations and summarizes the effect of the different mutations on tau functioning. In addition, the role of tau as a genetic susceptibility factor is discussed, together with the genetic evidence for additional causal genes for tau-positive as well as tau-negative dementia.

Original languageEnglish (US)
Pages (from-to)277-295
Number of pages19
JournalHuman Mutation
Volume24
Issue number4
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Tauopathies
Frontotemporal Dementia
Mutation
Pick Disease of the Brain
Progressive Supranuclear Palsy
Chromosomes, Human, Pair 17
Microtubule-Associated Proteins
Tubulin
Genetic Predisposition to Disease
Neurodegenerative Diseases
Transgenic Mice
Genes
Dementia
Alzheimer Disease

Keywords

  • Alzheimer
  • Frontotemporal dementia
  • Linkage
  • MAPT
  • Microtubule
  • Pick
  • Tau

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

The role of tau (MAPT) in frontotemporal dementia and related tauopathies. / Rademakers, Rosa V; Cruts, M.; Van Broeckhoven, C.

In: Human Mutation, Vol. 24, No. 4, 2004, p. 277-295.

Research output: Contribution to journalArticle

Rademakers, Rosa V ; Cruts, M. ; Van Broeckhoven, C. / The role of tau (MAPT) in frontotemporal dementia and related tauopathies. In: Human Mutation. 2004 ; Vol. 24, No. 4. pp. 277-295.
@article{fb6dc433aa484b69acd2c445b056583a,
title = "The role of tau (MAPT) in frontotemporal dementia and related tauopathies",
abstract = "Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. In patients diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17, mutations in the gene encoding tau (MAPT) have been identified that disrupt the normal binding of tau to tubulin resulting in pathological deposits of hyperphosphorylated tau. Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration. In the last five years, extensive research has identified 34 different pathogenic MAPT mutations in 101 families worldwide. In vitro, cell-free and transfected cell studies have provided valuable information on tau dysfunction and transgenic mice carrying human MAPT mutations are being generated to study the influence of MAPT mutations in vivo. This mutation update describes the considerable differences in clinical and pathological presentation of patients with MAPT mutations and summarizes the effect of the different mutations on tau functioning. In addition, the role of tau as a genetic susceptibility factor is discussed, together with the genetic evidence for additional causal genes for tau-positive as well as tau-negative dementia.",
keywords = "Alzheimer, Frontotemporal dementia, Linkage, MAPT, Microtubule, Pick, Tau",
author = "Rademakers, {Rosa V} and M. Cruts and {Van Broeckhoven}, C.",
year = "2004",
doi = "10.1002/humu.20086",
language = "English (US)",
volume = "24",
pages = "277--295",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The role of tau (MAPT) in frontotemporal dementia and related tauopathies

AU - Rademakers, Rosa V

AU - Cruts, M.

AU - Van Broeckhoven, C.

PY - 2004

Y1 - 2004

N2 - Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. In patients diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17, mutations in the gene encoding tau (MAPT) have been identified that disrupt the normal binding of tau to tubulin resulting in pathological deposits of hyperphosphorylated tau. Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration. In the last five years, extensive research has identified 34 different pathogenic MAPT mutations in 101 families worldwide. In vitro, cell-free and transfected cell studies have provided valuable information on tau dysfunction and transgenic mice carrying human MAPT mutations are being generated to study the influence of MAPT mutations in vivo. This mutation update describes the considerable differences in clinical and pathological presentation of patients with MAPT mutations and summarizes the effect of the different mutations on tau functioning. In addition, the role of tau as a genetic susceptibility factor is discussed, together with the genetic evidence for additional causal genes for tau-positive as well as tau-negative dementia.

AB - Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. In patients diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17, mutations in the gene encoding tau (MAPT) have been identified that disrupt the normal binding of tau to tubulin resulting in pathological deposits of hyperphosphorylated tau. Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration. In the last five years, extensive research has identified 34 different pathogenic MAPT mutations in 101 families worldwide. In vitro, cell-free and transfected cell studies have provided valuable information on tau dysfunction and transgenic mice carrying human MAPT mutations are being generated to study the influence of MAPT mutations in vivo. This mutation update describes the considerable differences in clinical and pathological presentation of patients with MAPT mutations and summarizes the effect of the different mutations on tau functioning. In addition, the role of tau as a genetic susceptibility factor is discussed, together with the genetic evidence for additional causal genes for tau-positive as well as tau-negative dementia.

KW - Alzheimer

KW - Frontotemporal dementia

KW - Linkage

KW - MAPT

KW - Microtubule

KW - Pick

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=5044235577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5044235577&partnerID=8YFLogxK

U2 - 10.1002/humu.20086

DO - 10.1002/humu.20086

M3 - Article

C2 - 15365985

AN - SCOPUS:5044235577

VL - 24

SP - 277

EP - 295

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -